Analyze Diet
PloS one2013; 8(8); e71619; doi: 10.1371/journal.pone.0071619

A genome-wide association study identifies risk loci to equine recurrent uveitis in German warmblood horses.

Abstract: Equine recurrent uveitis (ERU) is a common eye disease affecting up to 3-15% of the horse population. A genome-wide association study (GWAS) using the Illumina equine SNP50 bead chip was performed to identify loci conferring risk to ERU. The sample included a total of 144 German warmblood horses. A GWAS showed a significant single nucleotide polymorphism (SNP) on horse chromosome (ECA) 20 at 49.3 Mb, with IL-17A and IL-17F being the closest genes. This locus explained a fraction of 23% of the phenotypic variance for ERU. A GWAS taking into account the severity of ERU, revealed a SNP on ECA18 nearby to the crystalline gene cluster CRYGA-CRYGF. For both genomic regions on ECA18 and 20, significantly associated haplotypes containing the genome-wide significant SNPs could be demonstrated. In conclusion, our results are indicative for a genetic component regulating the possible critical role of IL-17A and IL-17F in the pathogenesis of ERU. The associated SNP on ECA18 may be indicative for cataract formation in the course of ERU.
Publication Date: 2013-08-14 PubMed ID: 23977091PubMed Central: PMC3743750DOI: 10.1371/journal.pone.0071619Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research conducted a genome-wide association study on German warmblood horses to identify genetic risk factors linked to equine recurrent uveitis, a common eye disease in horses, and found significant single nucleotide polymorphisms on horse chromosomes that may influence the disease’s occurrence and severity.

Objective and Methodology

  • The research article focused on investigating risk loci or places in the genetic code linked to Equine Recurrent Uveitis (ERU), an eye condition prevalent among 3-15% of the horse population. The disease is recurrent, meaning it happens repeatedly over time.
  • The researchers conducted a Genome-Wide Association Study (GWAS), a common method used to identify genes associated with particular diseases. The study uses the Illumina equine SNP50 bead chip.
  • The study collected and analyzed a sample that consists of 144 German warmblood horses, a particular breed of horses. This research method is targeted and specific, intending to establish robust and reliable findings.

Study Findings

  • The GWAS found a significant connection between ERU and a specific single nucleotide polymorphism (SNP) on horse chromosome 20 (ECA 20) at 49.3 Mb. SNPs are variations at a single position in a DNA sequence among individuals. They can naturally occur in the DNA sequence and are frequently used in defining biological markers for diseases.
  • Two closest genes to the identified SNP on ECA 20 are IL-17A and IL-17F. These genes are potentially important in the pathogenesis or the development of ERU. They contribute to an estimated 23% of the phenotypic variance for ERU. Phenotypic variance refers to the observable physical or biochemical differences in an individual attributed to individual genetic traits.
  • A secondary GWAS that considered the severity of ERU found another significant SNP on ECA18, close to the crystalline gene cluster CRYGA-CRYGF. This region might have implications on cataract formation during the progression of ERU.
  • Further, the research also demonstrated considerable associated haplotypes within the genome-wide significant SNPs on ECA18 and 20. Haplotypes are a set of DNA variations, or polymorphisms, that tend to be inherited together and can be used to track the inheritance of disease in families.

Conclusion and Implications

  • Findings from the research suggest a genetic component in the regulation of the critical role of IL-17A and IL-17F in the development of ERU. Understanding these genetic components can lead to better prediction, prevention, and treatment strategies for this recurrent eye disease in horses.
  • The identified SNP on ECA18 may play a pivotal role in cataract formation in the process of ERU, providing another potential research direction for efforts to mitigate the effects of ERU in the horse population.

Cite This Article

APA
Kulbrock M, Lehner S, Metzger J, Ohnesorge B, Distl O. (2013). A genome-wide association study identifies risk loci to equine recurrent uveitis in German warmblood horses. PLoS One, 8(8), e71619. https://doi.org/10.1371/journal.pone.0071619

Publication

ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 8
Issue: 8
Pages: e71619

Researcher Affiliations

Kulbrock, Maike
  • Institute for Animal Breeding and Genetics, University of Veterinary Medicine Hannover, Hannover, Germany ; Clinic for Horses, University of Veterinary Medicine Hannover, Hannover, Germany.
Lehner, Stefanie
    Metzger, Julia
      Ohnesorge, Bernhard
        Distl, Ottmar

          MeSH Terms

          • Animals
          • Case-Control Studies
          • Genetic Loci / genetics
          • Genetic Predisposition to Disease
          • Genome-Wide Association Study
          • Germany
          • Horse Diseases / genetics
          • Horses / genetics
          • Linear Models
          • Recurrence
          • Risk Factors
          • Uveitis / genetics
          • Uveitis / veterinary

          Conflict of Interest Statement

          Competing Interests: The authors have declared that no competing interests exist.

          References

          This article includes 47 references
          1. Vandenbroeck K. Cytokine gene polymorphisms and human autoimmune disease in the era of genome-wide association studies. J Interferon Cytokine Res 32: 139–151.
            pmc: PMC3319933pubmed: 22191464
          2. Gilger BC. Equine recurrent uveitis. The viewpoint from the USA. Equine Vet J Suppl 37: 57–61.
            pubmed: 20939168
          3. Kalsow CM, Dwyer AE. Retinal immunopathology in horses with uveitis. Ocul Immunol Inflamm 6: 239–251.
            pubmed: 9924920
          4. Deeg CA. Ocular immunology in equine recurrent uveitis. Vet Ophthalmol 11 Suppl 161–65.
            pubmed: 19046272
          5. Deeg CA, Hauck SM, Amann B, Pompetzki D, Altmann F. Equine recurrent uveitis - a spontaneous horse model of uveitis. Ophthalmic Res 40: 151–153.
            pubmed: 18421230
          6. Deeg CA. A proteomic approach for studying the pathogenesis of spontaneous equine recurrent uveitis (ERU). Vet Immunol Immunopathol 128: 132–136.
            pubmed: 19026452
          7. Spiess BM. Equine recurrent uveitis. The European viewpoint. Equine Vet J Suppl 37: 50–56.
            pubmed: 20939167
          8. Alexander CS, Keller H. Etiology and occurrence of periodic eye inflammation of horses in the area of Berlin. Tierärztl Prax 18: 623–627.
            pubmed: 2080508
          9. Szemes PA, Gerhards H. Untersuchungen zur Prävalenz der equinen rezidivierenden Uveitis im Großraum Köln-Bonn. Prakt Tierarzt 81: 408–420.
          10. Lowe RC. Equine uveitis: A UK perspective. Equine Vet J Suppl 37: 46–49.
            pubmed: 20939166
          11. Abrams K, Brooks L, Dennis E. Equine recurrent uveitis: Current concepts in diagnosis and treatment. Equine Pract 12: 27–34.
          12. Dwyer AE, Gilger BC. Equine recurrent uveitis. In: Gilger BC, editor. Equine Ophthalmology. Philadelphia: Elsevier Saunders. 285–322.
          13. Dwyer AE, Crockett RS, Kalsow CM. Association of leptospiral seroreactivity and breed with uveitis and blindness in horses: 372 cases (1986–1993). J Am Vet Med Assoc 207: 1327–1331.
            pubmed: 7591929
          14. Tömördy E, Hässig M, Spiess MB. The outcome of pars plana vitrectomy in horses with equine recurrent uveitis with regard to the presence or absence of intravitreal antibodies against various serovars of Leptospira interrogans. Pferdeheilkunde 26: 251–254.
          15. Borstel von M, Oey L, Stutzberg-Minder K, Boevé M, Ohnesorge B. Direkter und indirekter Nachweis von Leptospiren aus Glaskörperproben von Pferden mit ERU. Pferdeheilkunde 26: 219–225.
          16. Brem S, Gerhards H, Wollanke B, Meyer P, Kopp H. 35 leptospira isolated from the vitreous body of 32 horses with recurrent uveitis (ERU). Berl Münch Tierärztl Wochenschr 112: 390–393.
            pubmed: 10598357
          17. Wollanke B, Gerhards H, Brem S, Kopp H, Meyer P. Intraocular and serum antibody titers to Leptospira in 150 horses with equine recurrent uveitis (ERU) subjected to vitrectomy. Berl Münch Tierärztl Wochenschr 111: 134–139.
            pubmed: 9581347
          18. Hartskeerl RA, Goris MG, Brem S, Meyer P, Kopp H. Classification of leptospira from the eyes of horses suffering from recurrent uveitis. J Vet Med B Infect Dis Vet Public Health 51: 110–115.
            pubmed: 15107036
          19. Wollanke B, Gerhards H, Brem S, Meyer P, Kopp H. Ätiologie der equinen rezidivierenden Uveitis (ERU): Autoimmunkrankheit oder intraokulare Leptospireninfektion?. Pferdeheilkunde 20: 327–340.
          20. Deeg CA, Thurau SR, Gerhards H, Ehrenhofer M, Wildner G. Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease. Eur J Immunol 32: 2598–2606.
            pubmed: 12207344
          21. Romeike A, Brugmann M, Drommer W. Immunohistochemical studies in equine recurrent uveitis (ERU). Vet Pathol 35: 515–526.
            pubmed: 9823593
          22. Gilger BC, Malok E, Cutter KV, Stewart T, Horohov DW. Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis. Vet Immunol Immunopathol 71: 17–28.
            pubmed: 10522783
          23. Deeg CA, Ehrenhofer M, Thurau SR, Reese S, Wildner G. Immunopathology of recurrent uveitis in spontaneously diseased horses. Exp Eye Res 75: 127–133.
            pubmed: 12137758
          24. Deeg CA, Pompetzki D, Raith AJ, Hauck SM, Amann B. Identification and functional validation of novel autoantigens in equine uveitis. Mol Cell Proteomics 5: 1462–1470.
            pubmed: 16690753
          25. Regan DP, Aarnio MC, Davis WS, Carmichael KP, Vandenplas ML. Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitis. Vet Ophthalmol 15: 145–152.
            pubmed: 22051225
          26. Cross RS. Equine periodic ophthalmia. Vet Rec 78: 8–13.
            pubmed: 5295030
          27. Angelos J, Oppenheim Y, Rebhun W, Mohammed H, Antczak DF. Evaluation of breed as a risk factor for sarcoid and uveitis in horses. Anim Genet 19: 417–425.
            pubmed: 3232865
          28. Deeg CA, Marti E, Gaillard C, Kaspers B. Equine recurrent uveitis is strongly associated with the MHC class I haplotype ELA-A9. Equine Vet J 36: 73–75.
            pubmed: 14756375
          29. Kaese HJ, Flickinger G, Valberg SJ, Mickelson JR, Binns MM. ELA microsatellite association with uveitis in the Appaloosa horse. Vet Ophthalmol 8 (abstract no 36): 437–450.
          30. NaYoung Y, Salmon JH, Gilger BC. Quantitative differences in mRNA expression of toll-like-receptors (TlR)-2, 4, and 9 in normal equine eyes and eyes with equine recurrent uveitis. J Vet Clin 26: 520–523.
          31. Zhang R, Qian J, Guo J, Yuan YF, Xue K. Suppression of experimental autoimmune uveoretinitis by Anti-IL-17 antibody. Curr Eye Res 34: 297–303.
            pubmed: 19373578
          32. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 27: 485–517.
            pubmed: 19132915
          33. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441: 235–238.
            pubmed: 16648838
          34. Shu Q, Yang P, Hou S, Li F, Chen Y. Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Behçets disease in a Chinese Han population. Hum Immunol 71: 988–991.
            pubmed: 20620187
          35. Jang WC, Nam YH, Ahn YC, Lee SH, Park SH. Interleukin-17F gene polymorphisms in Korean patients with Behçet’s disease. Rheumatol Int 29: 173–178.
            pubmed: 18769923
          36. Kim ES, Kim SW, Moon CM, Park JJ, Kim TI. Interactions between IL17A, IL23R, and STAT4 polymorphisms confer susceptibility to intestinal Behcet’s disease in Korean population. Life Sci 90: 740–746.
            pubmed: 22483685
          37. Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet’s disease. Clin Exp Immunol 168: 68–74.
            pmc: PMC3390496pubmed: 22385240
          38. Chi W, Yang P, Li B, Wu C, Jin H. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 119: 1218–1224.
            pubmed: 17335887
          39. Chu M, Yang P, Hu R, Hou S, Li F. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 52: 7084–7089.
            pubmed: 21810982
          40. Yang Y, Xiao X, Li F, Du L, Kijlstra A. Increased IL-7 expression in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 53: 1012–1017.
            pubmed: 22247488
          41. Gilger BC, Yang P, Salmon JH, Jaffe GJ, Allen JB. Expression of a chemokine by ciliary body epithelium in horses with naturally occurring recurrent uveitis and in cultured ciliary body epithelial cells. Am J Vet Res 63: 942–947.
            pubmed: 12118672
          42. Blalock EL, Chien H, Dix RD. Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis. Cytokine .
            pmc: PMC3595332pubmed: 23415673doi: pii:s1043-4666(13)00039-2google scholar: lookup
          43. Cartier M, Breitman ML, Tsui LC. A frameshift mutation in the gamma-E-crystallin gene of the Elo mouse. Nature Genet 2: 42–45.
            pubmed: 1303247
          44. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 81: 559–575.
            pmc: PMC1950838pubmed: 17701901
          45. Bradbury PJ, Zhang Z, Kroon DE, Casstevens TM, Ramdoss Y. TASSEL: software for association mapping of complex traits in diverse samples. Bioinformatics 23: 2633–2635.
            pubmed: 17586829
          46. Pritchard J, Stephens M, Rosenberg N, Donnelly P. Association mapping in structured populations. Am J Hum Genet 67: 170–181.
            pmc: PMC1287075pubmed: 10827107
          47. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263–265.
            pubmed: 15297300

          Citations

          This article has been cited 18 times.
          1. Kirmse L, Thieme K, Doherr MG, Eule JC. Evaluation of Laboratory Techniques for the Diagnosis of Leptospira-Associated Equine Recurrent Uveitis (ERU) With Focus on the Goldmann-Witmer Coefficient. Vet Ophthalmol 2026 Jan;29(1):e70132.
            doi: 10.1111/vop.70132pubmed: 41518147google scholar: lookup
          2. Kingsley NB, Sandmeyer L, Dwyer A, Langefeld CD, McMullen RJ Jr, McCue M, Lassaline M, Bellone RR. A genome-wide investigation of insidious uveitis in Appaloosa horses. BMC Genomics 2025 Oct 9;26(1):904.
            doi: 10.1186/s12864-025-12099-3pubmed: 41068571google scholar: lookup
          3. Stafford LS, Plummer CE, Smith WC, Gibson DJ, Sharma J, Vicuna V, Diakite S, Larkin J 3rd. A peptide mimic of SOCS1 modulates equine peripheral immune cells in vitro and ocular effector functions in vivo: implications for recurrent uveitis. Front Immunol 2024;15:1513157.
            doi: 10.3389/fimmu.2024.1513157pubmed: 39867889google scholar: lookup
          4. Allen R, Goodhead AD. A survey of ocular pathology in Warmblood horses in South Africa. Equine Vet J 2025 Jul;57(4):889-897.
            doi: 10.1111/evj.14427pubmed: 39535442google scholar: lookup
          5. Zeng J, Wu M, Zhou Y, Zhu M, Liu X. Neutrophil Extracellular Traps (NETs) in Ocular Diseases: An Update. Biomolecules 2022 Oct 8;12(10).
            doi: 10.3390/biom12101440pubmed: 36291649google scholar: lookup
          6. Plummer CE, Polk T, Sharma J, Bae SS, Barr O, Jones A, Kitchen H, Wilhelmy M, Devin K, Clay Smith W, Kolaczkowski BD, Larkin J 3rd. Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide. Sci Rep 2022 May 3;12(1):7177.
            doi: 10.1038/s41598-022-11338-xpubmed: 35505065google scholar: lookup
          7. Fingerhut L, Yücel L, Strutzberg-Minder K, von Köckritz-Blickwede M, Ohnesorge B, de Buhr N. Ex Vivo and In Vitro Analysis Identify a Detrimental Impact of Neutrophil Extracellular Traps on Eye Structures in Equine Recurrent Uveitis. Front Immunol 2022;13:830871.
            doi: 10.3389/fimmu.2022.830871pubmed: 35251020google scholar: lookup
          8. Wollanke B, Gerhards H, Ackermann K. Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis. Microorganisms 2022 Feb 7;10(2).
          9. Degroote RL, Deeg CA. Immunological Insights in Equine Recurrent Uveitis. Front Immunol 2020;11:609855.
            doi: 10.3389/fimmu.2020.609855pubmed: 33488614google scholar: lookup
          10. Fingerhut L, Ohnesorge B, von Borstel M, Schumski A, Strutzberg-Minder K, Mörgelin M, Deeg CA, Haagsman HP, Beineke A, von Köckritz-Blickwede M, de Buhr N. Neutrophil Extracellular Traps in the Pathogenesis of Equine Recurrent Uveitis (ERU). Cells 2019 Nov 27;8(12).
            doi: 10.3390/cells8121528pubmed: 31783639google scholar: lookup
          11. Raudsepp T, Finno CJ, Bellone RR, Petersen JL. Ten years of the horse reference genome: insights into equine biology, domestication and population dynamics in the post-genome era. Anim Genet 2019 Dec;50(6):569-597.
            doi: 10.1111/age.12857pubmed: 31568563google scholar: lookup
          12. Paschalis-Trela K, Cywińska A, Trela J, Czopowicz M, Kita J, Witkowski L. The prevalence of ocular diseases in polish Arabian horses. BMC Vet Res 2017 Nov 7;13(1):319.
            doi: 10.1186/s12917-017-1252-8pubmed: 29115950google scholar: lookup
          13. Sandmeyer LS, Bauer BS, Feng CX, Grahn BH. Equine recurrent uveitis in western Canadian prairie provinces: A retrospective study (2002-2015). Can Vet J 2017 Jul;58(7):717-722.
            pubmed: 28698690
          14. Malalana F, Blundell RJ, Pinchbeck GL, Mcgowan CM. The role of Leptospira spp. in horses affected with recurrent uveitis in the UK. Equine Vet J 2017 Nov;49(6):706-709.
            doi: 10.1111/evj.12683pubmed: 28321895google scholar: lookup
          15. Simeonova GP, Krastev SZ, Simeonov RS. Immunological and pathological investigations in equine experimental uveitis. Vet Res Commun 2016 Dec;40(3-4):107-115.
            doi: 10.1007/s11259-016-9659-4pubmed: 27344152google scholar: lookup
          16. Finno CJ, Aleman M, Higgins RJ, Madigan JE, Bannasch DL. Risk of false positive genetic associations in complex traits with underlying population structure: a case study. Vet J 2014 Dec;202(3):543-9.
            doi: 10.1016/j.tvjl.2014.09.013pubmed: 25278384google scholar: lookup
          17. Wang Z, Zhang H, Yang H, Wang S, Rong E, Pei W, Li H, Wang N. Genome-wide association study for wool production traits in a Chinese Merino sheep population. PLoS One 2014;9(9):e107101.
            doi: 10.1371/journal.pone.0107101pubmed: 25268383google scholar: lookup
          18. Finno CJ, Bannasch DL. Applied equine genetics. Equine Vet J 2014 Sep;46(5):538-44.
            doi: 10.1111/evj.12294pubmed: 24802051google scholar: lookup